PropertyValue
?:definition
  • Molecular assay reagents intended to identify mutations in genes associated with leukoencephalopathy with vanishing white matter, a neurological disorder characterized by progressive cerebellar ataxia, spasticity, and cognitive impairment. Genetic variants at multiple loci have been associated with leukoencephalopathy with vanishing white matter. These reagents are intended to detect mutations in multiple leukoencephalopathy with vanishing white matter-associated loci simultaneously.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C4286251_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C4286251_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all